- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Imaging's Weekly Scan: Nov. 27, 2020
Low-dose CT for lung cancer screening offers significant benefits for detection and follow-up, but utilization, to date, has been low. Debra S. Dyer, M.D., chair of the American College of Radiology's Lung Cancer Screening 2.0 Committee discusses what the screening provides and the challenges to more widespread implementation.
Welcome to Diagnostic Imaging. I’m senior editor, Whitney Palmer
It’s Lung Cancer Awareness month, and one of the biggest advancements in the detection of the disease in recent years has been low-dose CT for screening. Not only does this technique offer a way to pinpoint whether a patient has lung cancer without exposing him or her to high levels of radiation, but it also provides a safe way to conduct multiple follow-up scans, as needed.
However, to date, utilization of this low-dose method has fallen well below expectations and hopes. With only 4.5 percent to 5 percent of eligible patients actually getting scanned, there’s a lot of room for improvement. This week, Diagnostic Imaging spoke with Dr. Debra Dyer, chair of the American College of Radiology’s Lung Cancer Screening 2.0 Committee about the benefits of low-dose CT, the challenges that exist to wider adoption and implementation, and what providers and facilities can do to increase screening rates.
Here’s what she had to say.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
